Depending on your treatment history, TECENTRIQ can be taken alone or with other medicines
TECENTRIQ was studied in 4 clinical trials with over 2000 people with metastatic NSCLC.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.